A distinct innate immune signature marks progression from mild to severe COVID-19

Mass cytometry and Olink data generated in the context of the characterization of the innate immune response to SARS-CoV-2 infection in a cohort of 70 covid-19 patients and 22 healthy individual collected in 4 hospital in Zürich (Switzerland) in spring 2020.

本数据集包含为表征70名新冠病毒（SARS-CoV-2）感染患者与22名健康个体的先天免疫应答所产生的质谱流式细胞术（Mass cytometry）与Olink检测数据（Olink），该研究队列于2020年春季在瑞士苏黎世的4家医院完成样本采集。